Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Idexx Laboratories (NQ: IDXX )

512.27 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Idexx Laboratories

< Previous 1 2 3 4 5 6 7 8 9 Next >
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
Via Benzinga
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
From IDEXX Laboratories, Inc.
Via Business Wire
$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
Via Benzinga
Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst
Idexx Laboratories reported a 15% rise in Q2 adjusted EPS to $3.02, surpassing the $2.88 consensus. Sales hit $1 billion, up 6%, with Companion Animal Group and Water revenue growth leading. Gross... 
Via Benzinga
Analyst Ratings For IDEXX Laboratories
Via Benzinga
P/E Ratio Insights for IDEXX Laboratories
Via Benzinga
Looking Into IDEXX Laboratories's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Via Benzinga
IDXX Stock Earnings: IDEXX Laboratories Beats EPS, Beats Revenue for Q2 2024
IDXX stock results show that IDEXX Laboratories beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
IDEXX Laboratories Announces Second Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
From IDEXX Laboratories, Inc.
Via Business Wire
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today
Via Benzinga
7 ‘Lottery Ticket Stocks’ That Could Turn $1K into $10K
Aggressive investors take note: these seven high-risk. high-reward stocks have the potential to rise in value by as much as 1,000%. 
Via InvestorPlace
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,600 Today
Via Benzinga
How Is The Market Feeling About IDEXX Laboratories?
Via Benzinga
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today
Via Benzinga
7 Surefire Stocks to Buy Each Time You Get a Paycheck
These seven surefire stocks across diverse sectors offer sticky revenue, consistent performance, and long-term compounding potential. 
Via InvestorPlace
Barking Up the Right Tree: 3 Top Pet Stocks With ‘Pawsitive’ Returns
Investors looking for pet stocks to buy will be barking up the right tree with these companies that sell products for all kinds of animals. 
Via InvestorPlace
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,500 Today
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today
Via Benzinga
$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today
Via Benzinga
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally
The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflation report that boosted risk sentiment among bullish investors. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day
From IDEXX Laboratories, Inc.
Via Business Wire
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Invest smarter with Wall Street's exchange-traded funds and seize market momentum with these thematic ETFs to buy. 
Via InvestorPlace
Topics ETFs
Aging Pet Population Is 'Solid Longer-Term Tailwind' For IDEXX Labs: Analyst
IDEXX Laboratories reports Q1 EPS of $2.81 (up 10% Y/Y), with sales reaching $964M (7% increase). Revenue growth driven by Companion Animal Group and Water segments. Operating margin at 31.0%. 2024... 
Via Benzinga
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
Despite the post-pandemic slowdown, the pet care industry remains healthy, as these three AI pet stocks to buy now demonstrate. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
IDXX Stock Earnings: IDEXX Laboratories Beats EPS, Misses Revenue for Q1 2024
IDXX stock results show that IDEXX Laboratories beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
IDEXX Laboratories Announces First Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.